发明名称 PHARMACEUTICAL COMPOSITION
摘要 PROBLEM TO BE SOLVED: To provide a pharmaceutical composition effective for the prevention and/or treatment of diseases such as arteriosclerosis, hyperlipemia and dyslipidemia to which the inhibition of cholesteryl ester transfer protein (CETP) is effective. SOLUTION: The pharmaceutical composition contains a compound expressed by general formula (I) (R<SP>1</SP>is an alkoxycarbonyl or the like; R<SP>2</SP>is an alkyl or the like; R<SP>3</SP>is hydrogen or the like; R<SP>4</SP>is an alkylene or the like; R<SP>5</SP>is a substituted heterocyclic group; R<SP>6</SP>, R<SP>7</SP>, R<SP>8</SP>and R<SP>9</SP>are each independently hydrogen, an alkyl, an alkoxy or the like; and R<SP>10</SP>is a (substituted)aromatic group or the like) or its pharmacologically permissible salt as an active component. COPYRIGHT: (C)2007,JPO&INPIT
申请公布号 JP2007119450(A) 申请公布日期 2007.05.17
申请号 JP20060261761 申请日期 2006.09.27
申请人 TANABE SEIYAKU CO LTD 发明人 KUBOTA HITOSHI;SUGAWARA MASAKATSU;FURUKAWA MARIKO;TAKANO MAYUMI;MOTOMURA DAISUKE
分类号 A61K31/5355;A61K31/4709;A61K31/506;A61K31/5377;A61K31/541;A61K31/55;A61P3/00;A61P3/04;A61P3/06;A61P3/10;A61P7/02;A61P9/00;A61P9/04;A61P9/06;A61P9/10;A61P9/12;A61P11/00;A61P13/12;A61P15/10;A61P25/28;A61P29/00;A61P31/04;A61P33/12;A61P35/00;A61P37/02;C07D401/12;C07D401/14;C07D405/14;C07D413/12;C07D413/14;C07D417/12;C07D419/14;C07D491/056 主分类号 A61K31/5355
代理机构 代理人
主权项
地址